Related Articles
Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder
Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer
Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization
Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: Comparative study of immunohistochemistry and fluorescent in situ hybridization
Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.